glp 1 agonist osteoporosis Effects of Glucagon-Like Peptide-1 receptor agonists on bone health in people living with obesity A study presented at the

See how GLP-1s are reshaping diabetes & obesity care.

Does retatrutide increase heart rate

Mounjaro is a newer option that targets two hormones and can be discussed with healthcare providers for suitable treatment plans

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.

This article explores current clinical evidence, provider decision-making frameworks, and how genetic insights may inform a personalized conversation with your healthcare

Despite the potential clinical benefits of GLP-1RA plus SGLT2i combination therapy in patients with T2DM, several factors may delay this combination to become a common practice soon, such as reimbursement and costs associated with polypharmacy